MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.dld.2015.09.014

Медицинская библиотека · Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2015

Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study.

Esteve Maria, Temiño Rocío, Carrasco Anna, Batista Lissette, Del Val Adolfo, Blé Michel, Santaolaria Santos, Molina-Infante Javier, Soriano Germán, Agudo Sandra, Zabana Yamile, Andújar Xavier, Aceituno Montserrat, Ribes Josepa, Madridejos Rosa, Fernández-Bañares Fernando

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

AIMS: (1) Assess the population-based incidence of severe olmesartan-associated enteropathy. (2) To describe patients of the Spanish registry. (3) Evaluate markers of potential coeliac disease and associated autoimmunity.

METHODS

Crude incidence rates in the area of Terrassa (Catalonia) were calculated. Clinical characteristics of patients in the Spanish registry were collected. Duodenal lymphocyte subpopulations and anti-TG2 IgA deposits were assessed in a subset of patients.

RESULTS

Annual incidence rates (2011-2014) ranged from 0 to 22 cases per 10(4) treated patients. Twenty patients were included in the Spanish registry. Nineteen (95%) exhibited villous atrophy and 16 (80%) had severe enteropathy. Lupus-like disease occurred during olmesartan treatment in 3 patients. HLA-DQ2/DQ8 was positive in 64%. Markers of potential coeliac disease were present in 4 out of 8 patients (positive anti-TG2 deposits and/or increased CD3+gammadelta+ intraepithelial lymphocytes and reduced CD3-). Histopathological changes and clinical manifestations including autoimmune disorders improved after olmesartan discontinuation but not after gluten-free diet, irrespective of the presence or absence of coeliac markers.

CONCLUSIONS

Incidence of severe olmesartan-associated enteropathy was low. Autoimmune phenomena were present in a subset of cases and reversed after olmesartan removal. A genetic coeliac disease background and the presence of potential coeliac markers might uncover predisposing factors.

Для цитирования: Esteve Maria, Temiño Rocío, Carrasco Anna, Batista Lissette, Del Val Adolfo, Blé Michel, Santaolaria Santos, Molina-Infante Javier, Soriano Germán, Agudo Sandra, Zabana Yamile, Andújar Xavier, Aceituno Montserrat, Ribes Josepa, Madridejos Rosa, Fernández-Bañares Fernando. Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study.. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2015. DOI: 10.1016/j.dld.2015.09.014.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.